HUMIRA*SC 2SIR+F 40MG 0,8ML+2T ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
96	Crohn disease	3

46. Malignant rheumatoid arthritis

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-003843-22-IT (EUCTR)	24/10/2006	30/08/2006	prospeCtive study on intensive early rheumatoid arthritis treatment with adalimUmab: induction of RE ...	prospeCtive study on intensive early rheumatoid arthritis treatment with adalimUmab: induction of RE ...	rheumatoid arthritis MedDRA version: 14.1;Level: HLT;Classification code 10039075;Term: Rheumatoid a ...	Trade Name: HUMIRASC 2SIR+F 40MG 0,8ML+2T INN or Proposed INN: Adalimumab Trade Name: METHOTREXATE10 ...	OSPEDALE POLICLINICO S. MATTEO	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Italy

First Previous1Next Last

96. Crohn disease

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-020137-10-IT (EUCTR)	07/11/2010	08/11/2010	An Open-Label, Multicenter, Efficacy and Safety Study to Evaluate Two Treatment Algorithms in Subjec ...	An Open-Label, Multicenter, Efficacy and Safety Study to Evaluate Two Treatment Algorithms in Subjec ...	Crohn`s disease. MedDRA version: 9.1;Level: LLT;Classification code 10011401	Trade Name: HUMIRA*SC 2SIR+F 40MG 0,8ML+2T INN or Proposed INN: Adalimumab Trade Name: Azathioprin-rat ...	Abbott GmBH & Co. KG	NULL	Not Recruiting	Female: yes Male: yes	240	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;Hungary;Czech Republic;Belgium;Spain;Lithuania;Austria;Netherlands;Germany;United Kingdom;Ita ...
2	EUCTR2005-005291-32-IT (EUCTR)	14/09/2006	13/12/2006	A multi-center, randomized, double-blind, placebo-controlled study on the Human Anti-TNF monoclonal ...	A multi-center, randomized, double-blind, placebo-controlled study on the Human Anti-TNF monoclonal ...	Crohn s disease MedDRA version: 9.1;Level: LLT;Classification code 10011401;Term: Crohn's disease	Trade Name: HUMIRA*SC 2SIR+F 40MG 0,8ML+2T INN or Proposed INN: Adalimumab	Abbott GmbH Co.KG	NULL	Not Recruiting	Female: yes Male: yes	130		Germany;Netherlands;Belgium;Italy;Austria;Sweden
3	EUCTR2004-002163-24-IT (EUCTR)	28/02/2005	15/06/2005	A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate th ...	A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate th ...	Crohn's disease MedDRA version: 14.1;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: HUMIRA*SC 2SIR+F 40MG 0,8ML+2T INN or Proposed INN: Adalimumab	Abbott GmBH Co KG	NULL	Not Recruiting	Female: yes Male: yes	960		Hungary;Spain;Denmark;Germany;United Kingdom;Italy

First Previous1Next Last